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OBJECTIVE: To determine the prevalence of anxiety and depression in patients complaining of chest pain who seek a chest pain 
unit attendance.
INTRODUCTION: Patients arriving at a Chest Pain Unit may present psychiatric disorders not identified, isolated or co-morbid 
to the main illness, which may interfere in the patient prognosis. 
METHODOLOGY: Patients were assessed by the “Hospital Anxiety and Depression Scale” as a screening instrument wile fol-
lowing a systematized protocol to rule out the diagnosis of acute coronary syndrome and other potentially fatal diseases. Patients 
with 8 or more points in the scale were considered “probable case” of anxiety or depression.
RESULTS: According to the protocol, 59 (45.4%) of 130 patients studied presented Chest Pain of Determined Cause, and 71 (54.6%) 
presented Chest Pain of Indefinite Cause. In the former group, in which 43 (33.1%) had acute coronary syndrome, 33.9% were 
probable anxiety cases and 30.5% depression cases. In the second group, formed by patients without acute coronary syndrome or 
any clinical conditions involving greater morbidity and mortality risk, 53.5% were probable anxiety cases and 25.4% depression.
CONCLUSION: The high anxiety and depression prevalence observed may indicate the need for early and specialized approach 
to these disorders. When coronary arterial disease is present, this may decrease complications and shorten hospital stay. When 
psychiatric disorder appears isolated, is possible to reduce unnecessary repeated visits to emergency room and increase patient’s 
quality of life.
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INTRODUCTION
Patients who arrive at the emergency room complaining 
of chest pain (CP) may present symptoms associated with 
psychiatric disorders, including anxiety and depression.¹ 
Upon assessing patients who presented atypical CP, Wulsin 
et al.² found that the two most common diagnoses included 
mood disorders and anxiety. A review study³ demonstrated 
that 30.1% of patients complaining of chest pain who 
arrived at the emergency room (ER) were diagnosed with 
a panic disorder (PD), of which 22.4% exhibited PD with 
no coronary artery disease (CAD). Patients with anxiety 
and depression disorders who were not diagnosed as such 
and thus were not appropriately treated had a tendency 
to complain of chronic symptoms and to regularly seek 
medical attention. In analyzing ER patients with atypical 
pain, Demiryoguran et al.4 observed a high probability of 
anxiety in 31.2% of these patients. In this group, 78.3% 
of the patients reported having previously received care 
in the ER for the same symptoms. Additional studies have 
demonstrated the excessive use of medical resources by 
certain of these patients5 who were characterized as having 
high anxiety and depression scores and low quality of life 210
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indices.6 The objective of the study described herein is to use 
a self-reporting measure to estimate the prevalence of anxiety 
and depression in patients admitted to chest pain units.
METHODS
Among the several instruments designed for psychiatric 
diagnoses, the Hospital Anxiety and Depression Scale 
(HADS) distinguishes itself from all other scales due to its 
ability to assess anxiety and depression without investigating 
somatic symptoms. HADS is often used to analyze a 
variety of diseases in the clinical setting.7 This method was 
developed in 1983 and consists of a series of 14 questions, 
7 of which are related to anxiety (HAD-A) while the other 7 
questions are related to depression (HAD-D). The creators8 
of the scale considered a score of less than 8 to indicate the 
lack of any mental disorder, a score equal to or greater than 
8 to indicate that a disorder was “probably” present, while 
a score above 10 was considered to indicate that a patient 
was “highly likely” to have a disorder. Validation of the 
Portuguese version,9 using the 8 to 9 transition as a cut-off 
point for each subscale demonstrated a 93.7% sensitivity for 
HAD-A and a 84.6% sensitivity for HAD-D in addition to 
a 72.6% specificity for HAD-A and a 90.3% specificity for 
HAD-D. The HADS has been used to help diagnose patients 
suffering from chest pain,10,11 atypical chest pain12 and heart 
disease.13 It has also been validated in non-cardiac patients 
complaining of chest pain.14 
The HADS was administered to chest pain (CP) patients 
admitted to the Chest Pain Unit (CPU) of a private hospital 
in Rio de Janeiro from May to August 2006. According 
to the unit stratification protocol, patients were referred 
to different acute coronary syndrome (ACS) investigation 
tracks according to the intensity of chest pain presented on 
arrival, classified as “definite angina” (Type A), “probable 
angina” (Type B), “probable non-angina” (Type C) and 
“definite non-angina” (Type D). Subsequently, the cardiac 
markers of patients were characterized. Upon admission and 
every 3 h thereafter, the serum creatine kinase-MB (CKMB) 
mass levels were measured in addition to the levels of serum 
troponin-I, which were analyzed upon admission and at 9 h 
post-admission. In addition, an 18-lead electrocardiogram 
was acquired upon admission and a 12-lead version was 
reacquired every 3 h thereafter. Moreover, we recorded a 
two-dimensional echocardiogram for most patients. In cases 
where no myocardial necrosis or rest ischemia was detected, 
a stress test using either a treadmill electrocardiogram or a 
single-photon emission computed tomographic myocardial 
scintigraphy was subsequently performed. 
We excluded patients with severe clinical conditions, 
severe respiratory failure, hemodynamic instability and 
neurological conditions with cognitive involvement. In 
addition, patients were excluded if diagnosed with dementia, 
delirium or any psychiatric disorder that causes changes in 
awareness or in formal thought processes. 
The HADS was administered by a nurse or physician 
who was on call at the CPU after patients had signed an 
informed consent form, during the waiting time between a 
blood test and its results or before a diagnostic procedure. 
If a patient presented a limitation in completing the HADS, 
such as difficulty reading, the health professional would 
offer assistance. The health professionals encouraged the 
patients to choose answers based on symptoms they had 
experienced during the previous week and asked them to 
provide spontaneous answers without excessive reflection.
The cut-off value used in this study was 8 for “probable” 
anxiety or depression. Every patient who presented a score 
greater than or equal to 8 in the “anxiety” or “depression” 
subscores of the HADS was referred to a psychiatrist at the 
hospital. When the diagnosis was subsequently confirmed, a 
specific treatment regimen was initiated in the CPU.
The current study was approved by the Ethics Committee 
consistent with the terms of the Helsinki Declaration. A 
bidirectional model was used for statistical analysis with 
a 5% level of statistical significance. SPSS for Windows 
version 13.0 was used for all analyses.
RESULTS
A total of 167 questionnaires were administered in this 
study and 37 potential recruits were excluded for a variety 
of reasons, including mistakes in filling the questionnaire, 
refusal to participate, transfer to another institution or 
inconclusive results. The 130 patients studied included both 
men (58.5%) and women (41.5%) between the ages of 31 
to 87 years with a mean age of 61.2 ± 12.1 years. The most 
frequent types of reported chest pain were Type B (38.5%) 
and Type C (49.2%) while Type A and Type D were reported 
significantly less frequently (10.8% and 1.5% of the cases, 
respectively). Overall, we observed higher than expected 
anxiety and depression scores upon administering the HADS 
method, as indicated by the mean scores of 7.33 ± 4.36 
and 4.78 ±3.92, respectively. A consistent predominance 
of probable anxiety cases was also observed - 44.6% of all 
cases were scored greater than or equal to 8, while 27.7% of 
the cases were determined to be likely depression sufferers 
with scores greater than or equal to 8. Of the 130 patients 
studied, 43 patients (33.1%) had acute coronary syndrome 
(ACS). In the latter group, a likely diagnosis of anxiety 
or depression was recorded in 34.8% and 27.9% of all 
cases, respectively. Interestingly, of all of the patients who 
reported symptoms of stratified chest pain, 87 (66.9%) were 211
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not diagnosed with acute coronary syndrome (NACS). In 
this group of 87 NACS patients, 16 (18.4%) patients were 
diagnosed with a non-coronary cause of chest pain, such 
as that resulting from pleuritis or pneumonia. However, in 
71 of the NACS patients (54.6%), no cause for the chest 
pain was discovered prior to discharge from the CPU after 
investigating and dismissing clinical conditions that evolve 
with a greater risk of morbidity and mortality (Table 1). 
Thus we divide the population of 130 patients studied 
herein into two groups. The first group is composed of 59 
patients (45.4%) who were diagnosed as having chest pain 
of a determined cause (PDC) while the second group of 71 
patients (54.6%) were diagnosed as having chest pain of an 
indetermined cause (PIC).
The PDC group was composed of 43 ACS cases (72.9%) 
and 16 NACS cases (27.1%) under the given clinical 
diagnoses. Among the clinically diagnosed NACS cases, 
10.2% of the cases were characterized as coronary artery 
disease (CAD) not acute, 5% were patients who had been 
diagnosed with anxiety and 3.4% suffered from pleuritic 
pain. Other diagnoses included pneumonia, costochondritis, 
lymphatic fistula, exogenous intoxication and tonsillitis, each 
of which had an incidence of 1.7%. The mean age of this 
group, which consisted of 64.4% men and 35.6% women, 
was 60.4 ± 13.6 years . Type A pain, Type B pain, Type C 
pain and Type D pain was reported in 23.7%, 42.4%, 32.2% 
and 1.7% of the cases, respectively. The mean anxiety score 
as assessed by the HADS method for this group was 6.29 
± 3.96 points while the depression score was 4.86 ± 4.07 
points. Thus, 33.9% of the patients were characterized as 
likely suffering from anxiety while 30.5% of the cases were 
characterized as likely suffering from depression.
The aforementioned PIC group, which also consisted 
of several NACS cases with no clinical diagnosis, was 
composed of 53.5% men and 46.5% women with a mean age 
of 61.9 ± 12.8 years,. In this group, there were no reports of 
definite angina-related chest pain (Type A pain). The most 
common pain classification was type C, which was reported 
in 63.4% of the cases, followed by Type B pain (35.2%) 
and Type D pain (1.4%). In this group, the mean anxiety 
score was 8.20 ± 4.50 points and the mean depression score 
was 4.70 ± 3.82 points. Overall, 53.5% of the patients were 
characterized as likely suffering from anxiety while 25.4% 
were characterized as likely suffering from depression.
Table 1 - Demographic and clinical characteristics
  mean / n SD / %
Age 61.2 13.2
Gender M 76 58.5%
Pain type A 14 10.8%
  B 50 38.5%
  C 64 49.2%
  D 2 1.5%
Non Acute Coronary Syndrome 87 66.9%
Acute Coronary Syndrome 43 33.1%
Chest Pain of Indeterminate Cause 71 54.6%
Chest Pain of Determined Cause 59 45.4%
HADS-A 7.33 4.36
HADS-D 4.78 3.92
Anxiety  58 44.6%
Depression  36 27.7%
Table 2 - Chest Pain of Indeterminate Cause and Chest Pain of Determined Cause - Group comparisons
PIC PDC
Mean / n SD / % Mean / n SD / %
Age 61.9 12.8 60.4 13.6
Gender F 33 46.5% 21 35.6%
  M 38 53.5% 38 64.4%
Pain type (a) A 0 0% 14 23.7%
  B 25 35.2% 25 42.4%
  C 45 63.4% 19 32.2%
  D 1 1.4% 1 1.7%
HADS-A (b) 8.20 4.50 6.29 3.96
HADS-D 4.70 3.82 4.86 4.07
Anxiety (c) 38 53.5% 20 33.9%
Depression 18 25.4% 18 30.5%
(a) chi-square: 23.656, 3 df, p < 0.001; (b) t test p <0.011; (c) chi-square: 5.021, 1 df, p: 0.025.212
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In comparing the data gleaned from the PDC and PIC 
groups (Table 2), our statistical analysis indicates similarities 
between the demographic data but differences regarding the 
types of pain and the identified HADS scores. There was 
no statistically significant difference in terms of the mean 
age of the patients in the two groups (p = 0.768). In regard 
to gender, while there was a greater proportion of women 
in the PIC group, this difference did not achieve statistical 
significance (p = 0.210). Interestingly, the PDC group was 
composed of a significantly higher percentage of patients 
reporting Type A and Type B pain as compared with the 
PIC group, which was shown to have a higher percentage 
of patients reporting Type C pain (chi-square = 23.656; 3 
df; p< 0.001). In addition, the mean anxiety scores were 
significantly higher in the PIC group (p = 0.011), however, 
this statistically significant difference was not observed for 
the mean depression scores (p = 0.819). Using the HADS 
value of 8 as a cut-off point, we observed a significantly 
higher incidence of anxiety in the PIC group (chi-square = 
5.021, 1 df, p = 0.025) while the prevalence of depression 
was similar between the two groups (chi-square = 0.428, 1 
df, p = 0.513).
DISCUSSION
Our key result is the observation that among people 
who go to an emergency room (ER) complaining of chest 
pain, which was equivalent to 54.6% (71/130) of the 
patients in our study, patients belonging to the PIC group 
would have been discharged with a diagnosis of “no acute 
coronary syndrome or any other high risk disease” if the 
HADS method had not been administered. Among those 
cases, 53.5% were diagnosed as patients with a probable 
anxiety disorder while 25.3% were diagnosed as patients 
probably suffering from depression. With regard to the 
presence of anxiety, in comparison with the PDC group, the 
mean anxiety score was higher in the PIC group. A higher 
incidence of anxiety was also found in this group using a 
HADS cut-off point of eight. 
Despite the known limitation of this scale as a 
diagnostic method for research15 the application of this 
very simple test allowed for a significant improvement in 
the quality of care administered in the ER. Early diagnosis 
of anxiety or depression disorders ultimately decreased 
the frequency of ER visits, as well as the cost of treating 
these patients.16 On the other hand, the fact that patients are 
aware that their chest pain is “not due to a heart disease” 
has very little impact on the evolution of anxiety disorders. 
Clinical investigations17 even after coronary angiography18 
are generally unable to prevent new episodes of non-
coronary chest pain. 
Although a structured interview was not used to confirm 
the psychiatric diagnoses, in all at-risk cases the mental 
health care department was contacted and when indicated, 
the necessary treatment was administered in the CPU. In 
daily clinical practice, this scale was shown to be useful. 
A study among hospitalized cardiac patients19 found that 
identifying patients at risk for depression did not require 
a formal diagnostic tool, but could be achieved using the 
HADS. Moreover, the sensitivity and specificity of HADS 
have are already been well established.20 A review of 747 
studies using the HADS21 demonstrated a sufficient ability 
to assess the symptomatic severity and caseness of anxiety 
disorders and depression in somatic patients, psychiatric 
patients, primary care patients and in the general population. 
However, using the HADS provides higher estimates of 
depression incidence than the estimates obtained using a 
diagnostic test such as the PRIME-MD.22
Without a screening tool, the ability of ER staff to 
diagnose anxiety and depression is very limited. In regard to 
the NACS patients from the PDC group with clinical cause, 
we note that only 5% of the patients were diagnosed with 
anxiety. This observation is consistent with observations 
reported by other authors.23-25 In a study involving ER 
patients who had reported chest pain, Fleet et al.23 noticed 
that PD was identified in only 2% of the 108 cases examined. 
In a separate study,24 the diagnosis of a psychiatric disorder 
was made in only 1 out of 30 patients, demonstrating failure 
in 97% of cases. Using a self-reporting measure such as 
the HADS, it was possible to classify 33.9% of the patients 
from the PDC group as likely anxiety sufferers and 30.5% 
of patients from this group as probable depression cases. 
In addition, after observing patients during the first week 
following acute myocardial infarct, Martin et al.25 observed 
a HADS score greater than 8 for HAD-A questions and for 
HAD-D questions in 30.4% and 15.2% of the cases studied, 
respectively. The hazardous impact of anxiety and depression 
on the development of CAD,26-29 the effects on the prognosis 
of the psychiatric disease itself,30 and the excessive use 
of medical resources31 have been well established in the 
literature. Recently it was demonstrated that anxiety and 
depression predict more problematic adverse cardiac events 
in patients with stable CAD.32 Given the elevated rate of 
morbidity and mortality associated with depression among 
cardiac patients,33 the HADS may serve as a useful tool in 
identifying at-risk patients.19
CONCLUSIONS
A significant proportion of patients complaining of 
symptoms indicative of chest pain who were admitted to 
the emergency department at our facility had a diagnosable 213
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psychiatric illness. The HADS method is an easily applied 
screening method that can be incorporated into daily clinical 
practice at the ER to allow for the early diagnosis of anxiety 
and depression disorders in chest pain patients. 
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